Prognostic value of nodal ratios in node-positive breast cancer

被引:166
作者
Woodward, WA
Vinh-Hung, V
Ueno, NT
Cheng, YC
Royce, M
Tai, P
Vlastos, G
Wallace, AM
Hortobagyi, GN
Nieto, Y
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
[4] Vrije Univ Brussels, Ctr Oncol, Jette, Belgium
[5] Med Coll Wisconsin, Dept Oncol, Milwaukee, WI 53226 USA
[6] Univ New Mexico, Canc Res & Treatment Ctr, Dept Internal Med, Albuquerque, NM 87131 USA
[7] Univ New Mexico, Canc Res & Treatment Ctr, Dept Hematol Oncol, Albuquerque, NM 87131 USA
[8] Univ New Mexico, Canc Res & Treatment Ctr, Dept Surg, Albuquerque, NM 87131 USA
[9] Allan Blair Canc Ctr, Dept Radiat Oncol, Regina, SK, Canada
[10] Geneva Univ Hosp, Dept Obstet & Gynecol, Geneva, Switzerland
[11] Geneva Univ Hosp, Dept Senol, Geneva, Switzerland
[12] Geneva Univ Hosp, Dept Gynecol Oncol, Geneva, Switzerland
[13] Univ Navarra Clin, Dept Hematol, Pamplona, Spain
关键词
D O I
10.1200/JCO.2005.03.1526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The American Joint Committee on Cancer staging system for breast cancer was recently updated to reflect the impact of increasing the absolute number of positive lymph nodes on prognosis. However, numerous studies suggest that nodal ratios (absolute number of involved nodes-number of nodes resected) may have greater prognostic value than absolute numbers of involved nodes. Here we examine the data supporting the use of nodal ratios in breast cancer prognosis and consider the potential advantages and disadvantages of including nodal ratios in breast cancer staging. Methods A systematic review of the literature was conducted using the following search engines: http://www.google.com; Thomson's ISI Web of Science; PubMed. Results In multiple reports from both prospective and retrospectively collected data sets, nodal ratios have been shown to be significant predictors of outcome, including locoregional recurrence and overall survival. These studies span all stages of breast cancer and include various treatments as well as various statistical approaches. Conclusion There is considerable data supporting the use of nodal ratios in breast cancer prognosis. A thorough and methodological evaluation of the potential prognostic importance of nodal ratios in large multicenter data sets is merited and is currently being undertaken by the International Nodal Ratio Working Group.
引用
收藏
页码:2910 / 2916
页数:7
相关论文
共 42 条
[1]   ESTRADIOL RECEPTORS IN COMBINATION WITH NEU OR MYC ONCOGENE AMPLIFICATIONS MIGHT DEFINE NEW SUBTYPES OF BREAST-CANCER [J].
BOLUFER, P ;
MOLINA, R ;
RUIZ, A ;
HERNANDEZ, M ;
VAZQUEZ, C ;
LLUCH, A .
CLINICA CHIMICA ACTA, 1994, 229 (1-2) :107-122
[2]   Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer [J].
Bolwell, B ;
Andresen, S ;
Pohlman, B ;
Sobecks, R ;
Goormastic, M ;
Rybicki, L ;
Bell, K ;
Kalaycio, M .
BONE MARROW TRANSPLANTATION, 2001, 27 (08) :843-846
[3]   The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemothermpy [J].
Cheng, YC ;
Rondón, G ;
Yang, Y ;
Smith, TL ;
Gajewski, JL ;
Donato, ML ;
Shpall, EJ ;
Jones, R ;
Hortobagyi, GN ;
Champlin, RE ;
Ueno, NT .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (11) :794-804
[4]  
COATES A, 1995, ONCOLOGY, V52, P82
[5]   Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer [J].
Costa, LJM ;
Soares, HP ;
Gaspar, HA ;
Trujillo, LG ;
Santi, PX ;
Pereira, RS ;
de Santana, TL ;
Pinto, FN ;
del Giglio, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03) :304-306
[6]   Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer [J].
Cserni, G ;
Burzykowski, T ;
Vinh-Hung, V ;
Kocsis, L ;
Boross, G ;
Sinkó, M ;
Tarján, M ;
Bori, R ;
Rajtár, M ;
Tekle, E ;
Maráz, R ;
Baltás, B ;
Svébis, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) :519-524
[7]   A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node [J].
Farshid, G ;
Pradhan, M ;
Kollias, J ;
Gill, PG .
BREAST, 2004, 13 (06) :494-501
[8]  
FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765
[9]  
Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966
[10]  
FLETCHER G, 1980, TXB RADIOTHERAPY, P573